(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 13.47% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.99%.
Axogen's revenue in 2025 is $203,271,000.On average, 3 Wall Street analysts forecast AXGN's revenue for 2025 to be $10,073,670,864, with the lowest AXGN revenue forecast at $9,998,532,330, and the highest AXGN revenue forecast at $10,136,570,052. On average, 3 Wall Street analysts forecast AXGN's revenue for 2026 to be $11,740,844,457, with the lowest AXGN revenue forecast at $11,507,744,757, and the highest AXGN revenue forecast at $11,954,066,725.
In 2027, AXGN is forecast to generate $13,739,354,596 in revenue, with the lowest revenue forecast at $13,601,316,874 and the highest revenue forecast at $13,877,392,318.